Hugh M. Davis - 18 Nov 2024 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Matthew Rothman, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
3
Filing time
18 Nov 2024, 16:20:41 UTC
Next filing
03 Dec 2024

No securities are beneficially owned.